Reduced activity of SERPINE1, therefore, suggests that loss of FABP3’s function prompts endothelial cells away from a state of senescence and improves clot breakage, providing benefits against cardiovascular risk in aging and dysregulated clot formation in atherosclerosis (106). This evidence concerns the gene FABP3 and atherosclerosis.